ECHO Seminar: Matrizyme Pharma - Taking a Start-up from the Bench to the Cardiac Cath Lab
Mar 19, 2019
Please join us for an ECHO (Entrepreneurship for Cardiovascular Health Opportunities) seminar featuring Dr. Bradley Strauss (Founder, Matrizyme Pharma) on Tuesday Mar 19, 2019 (11 am – 12 pm) in the TBEP lounge (MaRS West Tower, 661 University Ave, 14th floor).
Dr. Strauss’ presentation entitled, "Matrizyme Pharma - Taking a Start-up from the Bench to the Cardiac Cath Lab”, will feature an overview of Matrizyme Pharma., its technologies and the story behind its success. Matrizyme Pharma is a biopharmaceutical company committed to developing innovative therapeutics focusing in the area of interventional cardiology.
Light refreshments will be served.
ECHO is an entrepreneurship training program, funded and organized in a partnership between (i) the Translational Biology and Engineering Program (TBEP), the University of Toronto component of the Ted Rogers Centre for Heart Research, and (ii) the Health Innovation Hub (H2i).